deltatrials
Unknown PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT03758664

Clinical Study of ICP-192 in Solid Tumors Patients

A Phase I/IIa, Multicenter, Open-Label Study to Assess the Safety, Tolerability, Pharmacokinetics of ICP-192 in Patients With Advanced Solid Malignancies

Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.

Conditions Solid Tumor
Interventions ICP-192
Updated 12 times since 2018 Last updated: Jul 5, 2022 Started: Dec 19, 2018 Primary completion: Dec 31, 2024 Completion: Dec 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Solid Tumor and is currently ongoing. Beijing InnoCare Pharma Tech Co., Ltd. leads this study, which shows 12 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Dec 2018 – ~Feb 2019 · 2 months · monthly snapshotNot Yet Recruiting~Feb 2019 – ~Jul 2019 · 5 months · monthly snapshotRecruiting~Jul 2019 – ~Sep 2019 · 2 months · monthly snapshotRecruiting~Sep 2019 – ~Apr 2020 · 7 months · monthly snapshotRecruiting~Apr 2020 – ~Jul 2020 · 3 months · monthly snapshotRecruiting~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshotRecruiting~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshotRecruiting~Jun 2021 – ~Sep 2022 · 15 months · monthly snapshotRecruiting~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotRecruiting~Feb 2025 – present · 17 months · monthly snapshotUnknown

Change History

12 versions recorded

  1. Feb 2025 — Present [monthly]

    Unknown PHASE1/PHASE2

    Status: Recruiting → Unknown

  2. Sep 2024 — Feb 2025 [monthly]

    Recruiting PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  4. Sep 2022 — Jul 2024 [monthly]

    Recruiting PHASE1_PHASE2

  5. Jun 2021 — Sep 2022 [monthly]

    Recruiting PHASE1_PHASE2

▶ Show 7 earlier versions

  1. Jan 2021 — Jun 2021 [monthly]

    Recruiting PHASE1_PHASE2

  2. Jul 2020 — Jan 2021 [monthly]

    Recruiting PHASE1_PHASE2

  3. Apr 2020 — Jul 2020 [monthly]

    Recruiting PHASE1_PHASE2

    Phase: PHASE1 → PHASE1_PHASE2

  4. Sep 2019 — Apr 2020 [monthly]

    Recruiting PHASE1

  5. Jul 2019 — Sep 2019 [monthly]

    Recruiting PHASE1

  6. Feb 2019 — Jul 2019 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  7. Dec 2018 — Feb 2019 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Beijing InnoCare Pharma Tech Co., Ltd.
Data source: Beijing InnoCare Pharma Tech Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations